countries to expedite their own approval<\/a> processes to distribute and administer the vaccine. It also enables UNICEF and the Pan-American Health Organization to obtain the vaccine for distribution in countries in need.<\/p>\nDr. Mari\u00e2ngela Sim\u00e3o, WHO Assistant-Director General for Access to Medicines and Health Products said, \u201cThis is a very positive step towards ensuring global access to COVID-19 vaccines. But I want to emphasize the need for an even greater global effort to achieve enough vaccine supply to meet the needs of priority populations everywhere.\u201d<\/p>\n
‘We encourage even more developers to come forward for review and assessment. It\u2019s vitally important that we secure the critical supply needed to serve all countries around the world and stem the pandemic,’ she added.
\nAccording to the World Health Organization, the emergency use listing assesses the suitability of the vaccine as well as the safety, efficacy, and quality of the vaccine.<\/p>\n
The Pfizer vaccine was authorized for emergency use in the United States<\/a> on December 11 while the Moderna vaccine was also authorized for emergency use later in December. The United Kingdom was one of the first countries to authorize the Pfizer vaccine emergency use on December 2.<\/p>\nThe WHO declared the Covid-19 outbreak a pandemic on March 11. According to Johns Hopkins University, more than 83.1 million people have been infected with the coronavirus worldwide, with over 1.81 million fatalities as of now.<\/p>\n
\n\t\t\t
\n\t\t\t <\/div><\/div>\n\t\t